{"id":913955,"date":"2025-11-26T07:05:50","date_gmt":"2025-11-26T12:05:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/"},"modified":"2025-11-26T07:05:50","modified_gmt":"2025-11-26T12:05:50","slug":"picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/","title":{"rendered":"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p>TUCSON, Ariz., Nov.  26, 2025  (GLOBE NEWSWIRE) &#8212; Picard Medical, Inc. (NYSE American: PMI) (\u201cPicard\u201d or the \u201cCompany\u201d), parent company of SynCardia Systems LLC, maker of the world\u2019s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that it will present\u00a0<em>in vitro<\/em> data on the fully implantable Emperor Total Artificial Heart (TAH) at the 31st Annual Meeting of the International Society for Mechanical Circulatory Support (ISMCS 2025), held in Vienna, Austria from December 1<sup>st<\/sup> through 4<sup>th<\/sup>, 2025.<\/p>\n<p>\n        <strong>Details of the presentation are below:<\/strong>\n      <\/p>\n<p>\n        <u>Date<\/u>: Thursday, December 4, 2025<br \/><u>Time:<\/u> 14:05 Central European Time (CET). <br \/><u>Session<\/u>: Mini Oral Session 3: Hemocompatibility and Heart\/Pump Interaction<br \/><u>Presentation Title<\/u>: \u201cThe Emperor Total Artificial Heart: A Next Generation, Fully Implantable Total Artificial Heart\u201d<br \/><u>Presenter<\/u>: Duffy Elmer, Engineering Project Manager, Picard Medical, Inc.<\/p>\n<p>The presentation will highlight benchtop performance data from the Emperor, SynCardia\u2019s fully implantable next generation Total Artificial Heart platform. The system uses an internal motor driven design that eliminates the need for any external pneumatic driver and is engineered to significantly improve patient mobility and quality of life.<\/p>\n<p>\n        <strong>About ISMCS 2025<\/strong><br \/>\n        <br \/>ISMCS 2025 is the 31st annual global congress of the International Society for Mechanical Circulatory Support. The meeting brings together researchers, clinicians, engineers and industry leaders in mechanical circulatory support. It provides a forum to review new clinical research, discuss emerging technologies, and highlight next generation device innovations.<\/p>\n<p>\n        <strong>About Picard Medical and SynCardia<\/strong>\n      <\/p>\n<p>Picard Medical, Inc. is the parent company of SynCardia Systems, LLC (\u201cSynCardia\u201d), the Tucson, Arizona\u2013based leader with the only commercially available total artificial heart technology for patients with end-stage heart failure. SynCardia develops, manufactures, and commercializes the SynCardia Total Artificial Heart (\u201cSTAH\u201d), an implantable system that assumes the full functions of a failing or failed human heart. It is the first artificial heart approved by both the FDA and Health Canada, and it remains the only commercially available artificial heart in the United States and Canada. With more than 2,100 implants performed at hospitals across 27 countries, the SynCardia Total Artificial Heart is the most widely used and extensively studied artificial heart in the world.<\/p>\n<p>For additional information about Picard Medical, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BpAl3KJieg1j5RoeIm3MQLBuHo1gsvVjjcSNwdgmkvlM8k-STY39HjYA481pldH06vxwZKTb_O8EqDD5z94RkmjobpWCB6-4x5TvFkbh5T6GcZt6nFE_TLC_QDWfdFMScdMBkyoGkyBztSHpUUKevBY2x5Wx-nc-j6nEHFdMiDzFFV28OUs6spkeIuKwZuX3T-FqRCXZd0Us1mXVLxB0tR-JeViFFBZywvV7ysSPyLSWffz-vLsw8okqCpFcvKfSF5Wy8Q_XtZBINeO_EdoFxHXUi3loIaCG3FhBnyV7ZpJz-b33hoFC6637mKNIwed8G2H2YMafJA3Vp1hkDaKoX6AzXjouvnbUJYfDtZfOg_RXbbysmrapjjk74kO9HGwOOLo-cC4qDD3y_KI1dRm5fNgVCFdsCeRL5gm5mpKFXpIdb9Q8_ARMyylIEa2rBCxR7aiwV0rUaf_aOefCzL3xF2hRe8PXaS7TSwRL6FtS8Qy_e-Z_bVXvQn2vN9PyVCCC-Do7659KN0Aoy3nptBqvSdi5B9LuuzqmsA07xhTvQNdaZ0aCbTIvKsVCGqzf2n0SH_otUExFCIOv0dgG2PfHvVoFAsaDh7SUqjvvtgBUAr-kpgnhFHyayUgrVK4GCtux8_U4FdBogMBAnllZ9ESCGPVcbgLT3Stnw6u7DffgX0rLAMAVmcbSaokUTetG7ZyQcb_-qoSRx83x4ybdilqQbC3YbETT3NHw3Nwi7Wro4Ls6IjlMAtnkeicwjt3YrA9xBiISEhmU9vxd5if_IajVTR-4SzvB3ETj2WUVaO7hvJ7Nqs7nKlpX0-YHueRSi7iDGHUpenY3N4u1Rdz-kcvq6mScFD0g3lIvBTDXr-Ld7IRYk2Mfi1InxVNSubAYx7L7UJXquzOiC-sz8k89eE98v-IcU3zs_HVmZhggRb0HcBqemltovgeCijEuTqdv1aPaOjz_aHiiGocTsFmihuwam9p3lzNLdPCXW7l8dasbe7R2nXpAuZpoZRhfQknjENpu\" rel=\"nofollow\" target=\"_blank\">www.picardmedical.com<\/a>\u00a0or review the Company\u2019s filings with the U.S. Securities and Exchange Commission at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qmEwIA3e_Py3TR2C_M93vZHoh-3YawiemxlLm8NmD0XI8H0LnBKjtI-I6wOkOAO3zzHYEaIFOZyqC2b-WFglX1THGZPdF-KkRbBNaTMBhUPgWhPtwNd9jFVgGBXhmYISolQTj9LYKROwQejHtvMVYS8tvrwzUPChx-Nc_zcKr_PtVRPzfyNPWyv85KeUAuInOXIwaBII_xGfkH_1tfjFxUNJrzz7cr6TO3OWqYJaaS4zj5wJuuA7A94t30x8U3wi4IleGGmMQf0ndSvoHv8IQwbdcGVy6HExL1iXsS5Nmok1fqbBGQ-lbWJ0h6Pn4fCPkjG-Nxq-mksWvcyiJi10zM9IyZ5xZHlFQyDy-IJ8CZWmJfgc-P6XnOUxqZqud0ZDcTF0I4Q4hcNppx5V94tmWY81LK3MiMY5WarOeBOdu3JkBIg0_ztvIPjq7-xS16aAnb_rg1IMcBGF0ekjvl90I0_fzAnk4pAETFdgkAMI5ukcgDUmdd3EhpP52FOlYJ2x5C48gc3oofCKr699TBPczaxT6i5MnESNgdPm4DuaPahHFjdYXSMVbRGQW116v5FPoG7Oa_abZH93Y4brSjgLRBHUKRD5UWo2hG4A79_n-A3iXc82Syy7BopesYofLljx4Bmmu7ua8xnrOiewtn-zR5vp95c_NrMVGaUuADEB8q7h4Zi1gx5C62bKqNOfrLLJ51MILi4VqtKqI19sDe7hDnmwJnLOz6vi-RZmSxuPbLTaRQftF0HeyPlAn63dwNCCSHCPXOMUs7G8_wvptATqbp1hzIrTS4-kTfFXDsA7VFk15m2DZnRKTE67rmVzxNdMvoj27ufuD851aivXIiLIjRGwkFJRa2zPEj6GEYa7mNAJ6F4_YUgoap4fE_wuTjZtBDiskjmt47IB4WnM7Q1_hnR50JuCTnH_WSXeutuWI9c=\" rel=\"nofollow\" target=\"_blank\">www.sec.gov<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company\u2019s expectations with respect thereto or any change in events, conditions, or circumstances on which any statement is based. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Registration Statement and related prospectus filed in connection with the initial public offering with the SEC. Copies are available on the SEC\u2019s website,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hQF-Ye74JIM5wi5FGfLij4AiIQfwKIuO42r7Cs3Y2J_xyL0nrNUS1ZxJaBxWuD76AgeJDKQrV10T5SP12ROjDbBuqjt_DVBugHvvn0evj7NW2LubthcPWyYzMsvG2RrCePbfZMoZ4OjKfq3SW6tbKGrVrtOxayfHrKxLVYMMEB98a1A_S81_6tWWwgwGfEeufnOFUe9V61fdd1tnXRuuBMdVtNgqlxAqO82YcrzuLURdeIoKbkP8Bv_Rugu5tId9\" rel=\"nofollow\" target=\"_blank\">http:\/\/www.sec.gov<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>\n        <u>Investors<\/u><br \/>\n        <br \/>Eric Ribner<br \/>Managing Director<br \/>LifeSci Advisors LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dH6-5DZLzi_2ZFf8Tk1hl5YkBd6Esu7aBB1JR-tTS2HFNUVPVhBy_piTFLE1VyV6ay5jvzy5G_6J82vZWeqInZQDdMccaGyBsahCXF7nbA0G4WXSeeqp_wrNQ5Rxj8SHSzKYnRapSHE4jwXl_59O1JmU3wYWnMmn1W-8y-_S4tyln_veSfUbZdpgvm4Cg3vuSt_A9QsStAZlKXgOuhARFI-vwuiIfMHnmMhSpYUMCjPNrtBGCsTb4aTDPkWOjD2W8P1MnZcNZm34LQrqBHsqMcqKkeAP_LUhPvzc0wkVpTo=\" rel=\"nofollow\" target=\"_blank\">eric@lifesciadvisors.com<\/a><\/p>\n<p>\n        <u>Picard Medical, Inc.\/SynCardia Systems, LLC<\/u><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G0phTdKrdrg1MxX-GLdYl2_CggGUN1mCrvNVmHVlrPh3C2-ZZigFYjCufGuiO3X0ku1N94OFoMS8PVG36Psp0LxdeG4EIAbRRNfYfKwPnLkX0WRg3_tZZnQ3_utxnGxKkDaxBhdWdCcWOb1bPGeTdLqBsxBM0tG-bPGI_CmqvsxqppoeSYh2UMXGiChbK0LCmP7DGSiceLgZumZt4Nu6eLTWJjn0lkowuqZXgW6YFh31ATZQFi0AjCgVWKfa92RbvXO83Or3L4JwlAMR7NnUBw==\" rel=\"nofollow\" target=\"_blank\">IR@picardmedical.com<\/a>\n      <\/p>\n<p>\n        <u>General\/Media<\/u><br \/>\n        <br \/>Brittany Lanza<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2RpUizcsCkhF5hIDrvJcfwjvOixWxq7VPgUulBjKEQbEd6F0XomI1R00d-y8rfH0yFvEm2pFGwwpe_oZd69vW1Dz-Ch6Nf5hnWntal02dYjeXaccVi8wwE5mdPWDbYOkjD_1OAXBaieGte-404bL-D5cJKS51CI6QPKp0sn4XI6lsBV5RLdERrq7Rty1ePzxG6-Qxj6QuDTAIusP711K_iGaO9m35rPGmkF7cyNE3UIBOc4dBGyIW3b5P3xYwEES6W9LCvqIkxHh5-i-C4i_bw==\" rel=\"nofollow\" target=\"_blank\">blanza@syncardia.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTg2YWUyZGQtZTNhYi00ZmZlLTk2NzEtMzE5MWIzZGIxN2EyLTUwMDE1MDk2Ni0yMDI1LTExLTI2LWVu\/tiny\/Picard-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TUCSON, Ariz., Nov. 26, 2025 (GLOBE NEWSWIRE) &#8212; Picard Medical, Inc. (NYSE American: PMI) (\u201cPicard\u201d or the \u201cCompany\u201d), parent company of SynCardia Systems LLC, maker of the world\u2019s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that it will present\u00a0in vitro data on the fully implantable Emperor Total Artificial Heart (TAH) at the 31st Annual Meeting of the International Society for Mechanical Circulatory Support (ISMCS 2025), held in Vienna, Austria from December 1st through 4th, 2025. Details of the presentation are below: Date: Thursday, December 4, 2025Time: 14:05 Central European Time (CET). Session: Mini Oral Session 3: Hemocompatibility and Heart\/Pump InteractionPresentation Title: \u201cThe Emperor Total Artificial Heart: A Next Generation, Fully Implantable Total &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-913955","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TUCSON, Ariz., Nov. 26, 2025 (GLOBE NEWSWIRE) &#8212; Picard Medical, Inc. (NYSE American: PMI) (\u201cPicard\u201d or the \u201cCompany\u201d), parent company of SynCardia Systems LLC, maker of the world\u2019s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that it will present\u00a0in vitro data on the fully implantable Emperor Total Artificial Heart (TAH) at the 31st Annual Meeting of the International Society for Mechanical Circulatory Support (ISMCS 2025), held in Vienna, Austria from December 1st through 4th, 2025. Details of the presentation are below: Date: Thursday, December 4, 2025Time: 14:05 Central European Time (CET). Session: Mini Oral Session 3: Hemocompatibility and Heart\/Pump InteractionPresentation Title: \u201cThe Emperor Total Artificial Heart: A Next Generation, Fully Implantable Total &hellip; Continue reading &quot;Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-26T12:05:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025\",\"datePublished\":\"2025-11-26T12:05:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/\"},\"wordCount\":561,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/\",\"name\":\"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==\",\"datePublished\":\"2025-11-26T12:05:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/","og_locale":"en_US","og_type":"article","og_title":"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025 - Market Newsdesk","og_description":"TUCSON, Ariz., Nov. 26, 2025 (GLOBE NEWSWIRE) &#8212; Picard Medical, Inc. (NYSE American: PMI) (\u201cPicard\u201d or the \u201cCompany\u201d), parent company of SynCardia Systems LLC, maker of the world\u2019s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that it will present\u00a0in vitro data on the fully implantable Emperor Total Artificial Heart (TAH) at the 31st Annual Meeting of the International Society for Mechanical Circulatory Support (ISMCS 2025), held in Vienna, Austria from December 1st through 4th, 2025. Details of the presentation are below: Date: Thursday, December 4, 2025Time: 14:05 Central European Time (CET). Session: Mini Oral Session 3: Hemocompatibility and Heart\/Pump InteractionPresentation Title: \u201cThe Emperor Total Artificial Heart: A Next Generation, Fully Implantable Total &hellip; Continue reading \"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-26T12:05:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025","datePublished":"2025-11-26T12:05:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/"},"wordCount":561,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/","name":"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==","datePublished":"2025-11-26T12:05:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjM0NCM3MjkyOTk2IzUwMDE1MDk2Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/picard-medical-to-present-the-next-generation-fully-implantable-syncardia-total-artificial-heart-at-ismcs-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=913955"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913955\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=913955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=913955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=913955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}